
    
      In front of a shortage of Caelyx, the implementation of an alternative treatment must be
      considered to treat patients with ovarian cancer in relapse, sensitive to platin: associate
      the carboplatin with another drug of the family of the doxorubicin: liposomal doxorubicin
      (MyocetÂ®).
    
  